Showing results (101-110 of 143) with videos related to

Sort By:
Pageof 15
Journal of the National Cancer Institute|October 1, 1983
Mitochondrial toxicity of 2,5-diaziridinyl-3,6-bis-(carboethoxyamino)-1,4-benzoquinoneM A Oberc-Greenwood, B H Smith, C Cooke, et al.
AJNR. American Journal of Neuroradiology|May 1, 1983
Glycolytic rate (PET) and contrast enhancement (CT) in human cerebral gliomasN J Patronas, R A Brooks, R L DeLaPaz, et al.
Journal of Neuro-Oncology|January 1, 1983
Membrane and cytoplasmic changes in 1,3-bis (2-chloroethyl)-1-nitrosourea (BCNU)-sensitive and resistant human malignant glioma-derived cell linesB H Smith, M Vaughan, M A Greenwood, et al.
Journal of Human Evolution|April 27, 2010
Dental development of the Taï Forest chimpanzees revisitedT M Smith, B H Smith, D J Reid, et al.
The American Journal of Pathology|May 1, 1987
Products of cells cultured from gliomas. VI. Immunofluorescent, morphometric, and ultrastructural characterization of two different cell types growing from explants of human gliomasP E McKeever, B H Smith, J A Taren, et al.
Brain Research|March 26, 1984
The beta-adrenergic receptor system in human glioma-derived cell lines: the mode of phosphodiesterase induction and the macromolecules phosphorylated by cyclic AMP-dependent protein kinaseN Shitara, T D Reisine, H Nakamura, et al.
Metabolic Brain Disease|December 1, 1986
Glucose metabolism in human gliomas: correspondence of in situ and in vitro metabolic rates and altered energy metabolismJ Galarraga, D J Loreck, J F Graham, et al.
Science (New York, N.Y.)|May 13, 1983
Lymphoid cell-glioma cell interaction enhances cell coat production by human gliomas: novel suppressor mechanismS J Dick, B Macchi, S Papazoglou, et al.
AJNR. American Journal of Neuroradiology|May 1, 1983
Positron emission tomographic study of suppression of gray-matter glucose utilization by brain tumorsR L DeLaPaz, N J Patronas, R A Brooks, et al.
International Journal of Radiation Oncology, Biology, Physics|April 1, 1983
Radiosensitization of hematopoietic precursor cells (CFUc) in glioblastoma patients receiving intermittent intravenous infusions of bromodeoxyuridine (BUdR)J B Mitchell, T J Kinsella, A Russo, et al.
Pageof 15